Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04629534 · ClinicalTrials.gov registry record · Phase 4

Mothers' Own Milk Optimization for Preterm Infants Project (MoMO PIP) Pilot Study

A Phase 4 study, sponsored by Medical University of South Carolina.

Terminated
Registry status
Phase 4
Development phase
8
Enrollment target

NCT04629534 is a Phase 4 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04629534, a Phase 4 study, was terminated before completion, sponsored by Medical University of South Carolina.

TERMINATED
Registry status
Phase 4
Development phase
8 participants
Enrollment target

Study Summary

The overall goal of this study is to assess maternal vitamin D status along with diet, and milk composition, and in turn, to evaluate if infant vitamin D status can be improved with increased maternal supplementation and diet education. The central hypothesis is that by maximizing maternal vitamin D status in breastfed, preterm infants (\<35 weeks), there will be an increase infant 25(OH)D status at 1,2, and 3 months of age.

Interventions

  • DRUG Cholecalciferol
  • DRUG High dose Cholecalciferol

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2021-05-06
Est. Completion 2022-04-01
Phase Phase 4

What the Registry Record Tells You About NCT04629534

The ClinicalTrials.gov registry entry for NCT04629534 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol is the first listed.

NCT04629534 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04629534 about?

NCT04629534 is a clinical study titled "Mothers' Own Milk Optimization for Preterm Infants Project (MoMO PIP) Pilot Study". The overall goal of this study is to assess maternal vitamin D status along with diet, and milk composition, and in turn, to evaluate if infant vitamin D status can be improved with increased maternal supplementation and diet education. The central hypothesis is that by maximizing maternal vitamin D...

What is the current status of trial NCT04629534?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2021-05-06. Estimated completion is 2022-04-01.

What interventions are being tested in trial NCT04629534?

The interventions under investigation include: Cholecalciferol (DRUG), High dose Cholecalciferol (DRUG).

Who is sponsoring clinical trial NCT04629534?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.